Methods. To test whether IL12B genetic polymorphisms might contribute to human TB susceptibility, we examined the genotype frequencies of 5 IL12B polymorphisms (at promoter, intron 2, intron 4, exon 5, and 3 untranslated region [UTR]) in 516 patients with TB and 514 healthy control subjects from the Hong Kong Chinese population.
One-third of the world's population is infected with Mycobacterium tuberculosis. Tuberculosis (TB) has reemerged as a leading global health threat, accounting for 8.7 million new cases and 1.7 million deaths every year [1] . It is inferred that a role is played by host genetic factors in TB susceptibility because 10% of infected individuals develop clinical disease [2] , there is higher disease concordance in monozygotic twins than in dizygotic twins [3, 4] , and infection rates differ among racial groups [5] .
The host genetic factors related to TB have been investigated via 3 different approaches. Linkage studies have identified 3 regions, at chromosome 2q35 [6] , 15q11-13 [7] , and Xq27 [8] , that have probable linkages to TB. Case-control association studies have found significant associations between gene polymorphisms in NRAMP1 [9] , HLA [10] , vitamin D receptor [11] , mannose-binding lectin [12] , interleukin (IL)-1 [13] , IL-1b, IL-1 receptor antagonist [14] , surfactant proteins [15] , P2X 7 [16] , interferon (IFN)-g [17] , IL-10 [18] , IL-12 receptor [19] , and IL-8 [20] and TB. Mendelian susceptibility to mycobacterial infections, which is caused by a mutation in a single major gene, indicates that a critical role is played by the IL-12-IFN-g cytokine axis in host immunity against the disease [21] . In knockout murine models, IL-12-deficient mice are more susceptible to infection with M. bovis bacille Calmette-Guérin [22] and M. tuberculosis [23] than are wild-type mice. In addition, IL12B-deficient mice develop more severe mycobacterial infection than do IL12A-deficient mice [24] .
IL-12 is a heterodimeric cytokine that is composed of 2 subunits, p35 and p40, and that plays an essential role in the induction and maintenance of Th1 responses [25] . Polymorphisms in IL12B have been reported at promoter [26] , intron 2 [27] , intron 4 [28] , exon 5 [26] GGTCATTGGCAGGTTGTTCT CGCCCATAGGGTAAGCAATA The polymorphism was a 7-bp deletion and 3-bp insertion, leading to an allelic difference of 4 bp. The shorter allele (1) and the longer allele (2) were genotyped by use of the ABI PRISM 700 Sequence Detection System (Applied Biosystems), with TaqMan probes (Applied Biosystems). Intron 2 [27] FAM-GACTGAGGAGTCAGCCAACTG TTGGCCTCAGTACGCTTCTT Allele 1 (ATT) 8 and allele 2 (ATT) 9 were amplified with fluorescence-labeled forward primers and were analyzed by use of ABI PRISM 377 DNA Sequencers and GeneScan software (version 3.1) (Applied Biosystems). Intron 4 [28] FAM-GTCATGGAGAGCTCCCCATA TGGCCAGAACTTTTCAATG Allele 1 (TA) 10 (TG) 10 and allele 2 (TA) 9 (TG) 9 were genotyped by the same method as that described for intron 2. Exon 5 [29] GAGGAGAGTCTGCCCATTGA GATCTGGGGCAAGTTGCTTA Allele serine (AGC) and allele asparagine (AAC) were distinguished by overnight digestion at 37؇C with Fnu4HI (New England Biolab), because allele serine gained a Fnu4HI site. 3 UTR [28, 30] TGATCCAGGATGAAAATTTGG GGCAACTTGAGAGCTGGAAA Allele 1 (A) and allele 2 (C) were genotyped by overnight digestion at 65؇C with TaqI (Invitrogen), because allele 2 created a TaqI restriction site.
NOTE. UTR, untranslated region. a The original reference paper(s) describing each IL12B polymorphism is provided. b The 2 alleles at each polymorphic locus are designated "1" and "2." c TaqMan probes used for the promoter allele were FAM-CCACATTAGAGCCTCTC and VIC-CCACAGCCCTCTCT. [29] , and 3 untranslated region (UTR) [28, 30] . The allelic variants at 3 UTR and promoter have different effects on IL12B mRNA [31] and IL-12p70 protein expression levels [26, 32] . Because IL-12 is a key Th1 cytokine that protects individuals from mycobacterial infection, we hypothesized that genetic polymorphisms in IL12B might contribute to TB susceptibility in the general population. To test this hypothesis, we first investigated whether any associations between 5 reported IL12B polymorphisms and TB could be found in 516 patients with TB and 514 healthy control subjects. Second, we performed functional analysis to correlate the associated polymorphisms with IL-12p70 protein expression. DNA extraction. Genomic DNA was isolated from whole blood that had been collected from patients with TB and from buffy-coat lymphocytes from control subjects, according to a standard procedure [34] or by use of a DNA extraction kit (Qiagen).
PATIENTS, MATERIALS, AND METHODS

Study
IL12B genotyping. The sequences of all primers and probes and the genotyping methods for 5 IL12B polymorphisms (at promoter, intron 2, intron 4, exon 5, and 3 UTR) are described in table 1. Each polymorphic locus consists of 2 alleles (designated "1" and "2") except for intron 4, where other minor alleles are also present (table 1). Polymerase chain reaction (PCR) was performed in a 50-mL reaction mixture containing 50 ng genomic DNA, 0.2 mmol/L primers, 1.5 mmol/L MgCl 2 , 0.2 mmol/L dNTPs, and 0.5 U Taq DNA polymerase (Amersham). The PCR mixture was incubated initially for 2 min at 95ЊC and was followed by 35 cycles of denaturation for 1 min at 95ЊC, annealing for 1 min at 60ЊC, and extension for 1 min at 72ЊC; final extension was for 5 min at 72ЊC.
Genotype analyses. The genotype frequencies of each of the IL12B polymorphisms were determined in the 516 patients with TB and the 514 control subjects (table 2). Because the allele frequency of asparagine (AAC) in exon 5 was !1%, this allele was considered an uncommon variant in the Hong Kong Chinese population, and exon 5 was excluded from further analyses. At each polymorphic locus, the genotype frequencies of the patients with TB and the control subjects were compared, and odds ratios (OR) were calculated by assigning the reference value (1.0) to the homozygous genotype that was more frequent in the control subjects than in the patients with TB. The OR and P values were calculated by multiple logistic regression a Genotype frequencies at each polymorphic locus were compared between the patients with TB and the control subjects, and ORs were calculated by assigning the reference value (1.0) to the homozygous genotype that was more frequent in the control subjects than in the patients with TB. The OR and P values were calculated by multiple logistic regression analysis, adjusted for the age and sex of the patients with TB and the control subjects. was considered to be significant.
b Repeats other than (TA) 10 (TG) 10 and (TA) 9 (TG) 9 were grouped together.
analysis, adjusted for the age and sex of the patients with TB and the control subjects. A P value !.05 was considered to be significant. In addition, we analyzed, for genotype frequency, the 306 culture-or smear-positive patients with TB from the entire cohort of 516 patients and compared them with the 514 control subjects. The genotype distributions of all 4 informative polymorphisms (at promoter, intron 2, intron 4, and 3 UTR) were tested for Hardy-Weinberg equilibrium (HWE) separately in the patients with TB and the control subjects, by x 2 test. Statistical analyses were conducted by use of SAS software (version 8.2; SAS Institute).
Haplotype analyses.
The frequencies of multiple-locus haplotypes composed of the IL12B promoter, intron 2, intron 4, and 3 UTR alleles were estimated by performing the haplotype procedure of the SAS/Genetics software (version 8.2; SAS Institute), which uses the expectation-maximization (EM) algorithm to generate maximum-likelihood estimates of haplotype frequencies given multiple genetic-marker genotypes under the assumption of HWE [35] (table 3) . To test the overall difference in haplotype frequency between the patients with TB and the control subjects, the haplotype procedure was performed for the patients, for the control subjects, and for the patients and control subjects combined. The relevant test statistic was defined as , where ln
L PC is the natural logarithm of the maximum-likelihood estimates for patients plus control subjects, ln L P is the natural logarithm of the maximum-likelihood estimates for the patients with TB, and ln L C is the natural logarithm of the maximumlikelihood estimates for the control subjects. With large sample sizes, the distribution of G approximates a x 2 distribution, with df equal to the number of haplotypes estimated [35] .
Diplotype analyses. We combined the genotype data of the 4 IL12B polymorphic loci for each of the 516 patients with TB and the 514 control subjects. The frequencies of the multiple-locus genotypes (termed "diplotypes") in the patients and control subjects are cross-tabulated in table 4. The overall difference in diplotype frequency between patients with TB and control subjects was evaluated by x 2 test. IL-12p70 assay. Peripheral-blood mononuclear cells (PBMCs) from 98 randomly selected control subjects were obtained, and the IL12B genotypes of each subject were determined. PBMCs were cultured at a concentration of cells/mL in 24-well, 6 1 ϫ 10 round-bottomed tissue-culture plates (Corning Costar), in 1 mL of RPMI 1640 medium (Gibco) with 10% fetal bovine serum (Gibco). The cells were stimulated with 100 ng/mL IFNg (R&D Systems) for 2 h at 37ЊC, followed by the addition of 10 ng/mL lipopolysaccharide (Sigma). Culture supernatants were harvested at 16 h, and IL-12p70 concentration was assayed in duplicate by ELISA, according to the manufacturer's instructions (DuoSet ELISA Development Kit; R&D Systems). Correlation of IL-12p70 protein levels and genetic polymorphisms was analyzed by the Mann-Whitney U test.
RESULTS
Association between 1/1 genotype of IL12B intron 2 and TB. Significant differences between the genotype frequencies of promoter, intron 2, intron 4, and 3 UTR polymorphisms of IL12B in patients with TB and those in control subjects were detected ( ) (table 2) . Intron 2 polymorphism showed the most P ! .05 significant result. Individuals homozygous for the 1/1 genotype of intron 2 had a 2.14-fold increased risk of developing TB (95% confidence interval [CI], 1.45-3.19 [ ]). Impor-P ! .001 tantly, the genotype analyses of the whole cohort of 516 patients with TB and of the subset of 306 culture-or smear-positive patients with TB yielded very similar genotype frequencies, ORs, and P values for all 4 informative IL12B polymorphisms (see the Appendix). In the latter analysis, the OR for the 1/1 genotype of intron 2 was 1.98, with a 95% CI of 1.25-3.13 and P value of .009. Therefore, we used the whole cohort of 516 patients with TB for subsequent analysis. The genotype frequencies of all 4 informative IL12B polymorphisms in the patients with TB and in the control subjects were in HWE, except for (1) excess homozygosity at promoter genotypes in the control subjects and (2) excess homozygosity and excess hetero- NOTE. The frequencies of multiple-locus haplotypes composed of IL12B promoter, intron 2, intron 4, and 3 UTR alleles were estimated by use of the expectation-maximization algorithm. Frequencies are given in percentages. An overall difference in haplotype frequency between the patients with TB and the control subjects was found ( ). The test statistic was defined as , where ln L PC is
the natural logarithm of the maximum-likelihood estimates for patients plus control subjects, ln L P is the natural logarithm of the maximum-likelihood estimates for the patients with TB, and ln L C is the natural logarithm of the maximum-likelihood estimates for the control subjects. CI, confidence interval; UTR, untranslated region. a Twelve haplotypes (designated "A-L") with frequencies 11% are shown.
zygosity at intron 2 and 3 UTR genotypes, respectively, in the patients with TB. Our sample of patients with TB consisted mainly of individuals who were newly diagnosed at territorywide chest clinics, which treat 190% of newly diagnosed patients with TB in Hong Kong. Furthermore, the cohort of 516 patients with TB had characteristics (male, 69.1%; mean age, 48.4 years [SD, 19.8 years]; pulmonary TB, 86.3%) that were similar to those in a large survey of 5757 patients with TB who registered for treatment in Hong Kong during 1996 [36] . Departure from HWE in the patients with TB probably represented the association between TB and the intron 2 allele and a particular haplotype in our population, rather than sampling bias. Associations between risk haplotypes (designated "A" and "K") of IL12B and TB and between a protective haplotype (designated "B") of IL12B and TB. Estimation of the haplotype frequencies from the diploid genotype data was performed by use of the EM algorithm [35] . In the total sample of patients with TB and control subjects, 12 of the 38 possible haplotypes composed of the promoter, intron 2, intron 4, and 3 UTR alleles of IL12B had frequencies 11% (table 3) . Most of the remaining haplotypes had frequencies of zero or of close to zero. We tested the genotype frequencies for HWE separately in the patients with TB and the control subjects and noted deviations from HWE in 1 locus in the control subjects and in 2 loci in the patients with TB, as described above. Estimation error might result from these HWE deviations. However, the HWE deviations in our sample were mainly due to excess homozygosity (2 of 3 loci), which caused little increase in error between the EM estimates and the sample values [37] . Haplotypes A and B account for ∼70% of the total haplotypes of IL12B in the Hong Kong Chinese population. An overall difference in haplotype frequency between the patients with TB and the control subjects was found ( ). Among the dif-P ! .001 ferent IL12B haplotypes, haplotypes A and K occurred at higher frequencies in the patients with TB than in the control subjects, whereas the converse was found for haplotype B, with no overlapping of the 95% CIs for the haplotype frequencies in the patients with TB and the control subjects (table 3) .
Associations between a risk diplotype (designated "I") of IL12B and TB and between a protective diplotype (designated "II") of IL12B and TB. We combined the genotypes at each of the 4 informative IL12B polymorphic loci (promoter, intron 2, intron 4, and 3 UTR) and observed 61 diplotypes in the patients with TB and the control subjects. In the total sample of patients and control subjects, one-quarter of the diplotypes had frequencies 11%. The remaining diplotypes were grouped together as "others" (table 4 ). An overall difference in diplotype frequency between patients with TB and control subjects was found ( ). Furthermore, diplotype I (composed of A and P ! .001 K haplotypes) was found to be strongly associated with TB, with 25 patients with TB and none of the control subjects showing the genotype pattern. In contrast, diplotype II (homozygous BB haplotypes) was underrepresented in patients with TB, compared with its frequency in control subjects (table 4) .
IL-12p70 expression levels and IL12B genetic polymorphisms. To investigate whether IL12B genetic polymorphisms NOTE. The frequencies of the multiple-locus genotypes (termed "diplotypes") in patients with TB and control subjects are crosstabulated here. An overall difference in diplotype frequency between the patients with TB and the control subjects was found (P ! , x 2 test). UTR, untranslated region. .001 a Thirteen diplotypes (designated "I"-"XIII") with frequencies 11% are shown.
are associated with gene expression, we stimulated PBMCs from 98 randomly selected control subjects for IL-12p70 production.
A stronger trend for IL-12p70 production was observed in haplotype B carriers ( ; median, 352 pg/mL), compared with n p 57 non-haplotype B carriers ( ; median, 283 pg/mL) (P p n p 41 .154), whereas a weaker trend for IL-12p70 production was observed in IL12B promoter heterozygotes ( ; median, n p 45 287 pg/mL), compared with IL12B promoter homozygotes ( , median, 357 pg/mL) ( ). Large variations in n p 53 P p .423 levels of IL-12p70 expression among individuals with the same IL12B genotypes were observed, and no statistical correlation between levels of IL-12p70 expression and specific IL12B genetic polymorphisms was found.
DISCUSSION
To test whether there is an association between IL12B polymorphisms and TB susceptibility, we performed a large-scale population-based case-control study involving 11000 individuals from the Hong Kong Chinese population. Whether the whole cohort of 516 patients with TB or just the 306 culture-or smearpositive patients were considered, the genotype analyses showed that individuals homozygous for the intron 2 (ATT) 8 allele of IL12B had a 2-fold increased risk for TB. Only one study has reported an association between intron 2 polymorphism of IL12B and clinical disease; in white American families, the intron 2 (ATT) 9 allele has been found to be preferentially transmitted to individuals with type 1 diabetes [27] . Our findings for patients with TB could reconcile with those for individuals with type 1 diabetes, because we found the intron 2 (ATT) 9 allele to be protective against an infectious disease such as TB, whereas the same allele appeared to be a risk factor for an autoimmune disease such as diabetes. This finding is consistent with the observation that IL-12 is a costimulator of protective immune responses as well as a mediator of immunopathological diseases.
We next estimated the frequencies of IL12B haplotypes composed of 4 informative polymorphic alleles at promoter, intron 2, intron 4, and 3 UTR and identified risk (A and K) and protective (B) haplotypes. In agreement with the genotype findings, the intron 2 (ATT) 8 allele was contained in the risk haplotypes A and K, whereas the alternative (ATT) 9 allele was contained in the protective haplotype B. Correlation of the haplotypes and the diplotypes revealed interesting results. Diplotype I (heterozygous A and K haplotypes) was found in only 25 patients with TB and in none of the control subjects. The other probable pairings of haplotypes for diplotype I were unlikely, because they involved haplotypes with low frequencies and at least 1 haplotype with a frequency !1% (tables 3 and 4). Because diplotype IV (homozygous AA haplotypes) occurred at similar frequencies in patients with TB and control subjects, it was inferred that haplotype K might be strongly linked to a TB-susceptibility locus.
In contrast to haplotypes A and K, haplotype B was found to confer resistance to TB. Both diplotypes II (homozygous BB haplotypes) and III (heterozygous B and G haplotypes) occurred at higher frequencies in control subjects, compared with those in patients with TB. Diplotype II was found in twice the number of control subjects than in patients with TB, and diplotype III was found in 10 of the control subjects and in none of the patients with TB. The effect that haplotype G has on resistance to TB is probably small, because it was found to be rare in both the patients with TB and the control subjects. A particular IL12B haplotype (allele 2 at the promoter and allele 2 at 3 UTR) was found to be associated with fatal cerebral malaria in Tanzanians [38] . In our study population, 9% of patients with TB and 14% of control subjects were homozygous for this haplotype, which indicates that it plays a protective role against TB (OR, 0.60 [95% CI, 0.41-0.88]) ( ). P p .012 The discordant effects that the IL12B haplotype has on malaria and TB might reflect the complexity of the influence of IL-12 and its genetic polymorphisms on host immune responses against different infectious diseases.
We attempted to correlate the IL12B haplotypes and levels of IL-12p70 expression. A higher median level of IL-12p70 was observed in haplotype B carriers, compared with non-haplotype B carriers; however, the result did not reach statistical significance. We could not investigate the level of IL-12p70 expression in individuals with diplotype I, because of the low frequency of such individuals among the control subjects. To date, no functional studies have reported on IL12B intron 2 and 4 polymorphisms; conflicting results have been reported on the functional effects of 3 UTR polymorphisms. Morahan et al. [31] [32] demonstrated an association between significantly higher IL-12p70 protein levels and the 3 UTR 2/2 genotype, after stimulation of monocytes with Staphylococcus aureus strain Cowan and IFN-g. Such inconsistent results might be due in part to different experiment protocols, but they could also be due to factors other than IL12B genotypes regulating the expression of IL-12. We also found great variation in levels of IL-12p70 expression among individuals with the same IL12B genotypes. Furthermore, after multiple logistic regression, we did not observe any strong independent effect of 3 UTR polymorphism on TB susceptibility, which concurs with the observed lack of association between 3 UTR polymorphism of IL12B and TB susceptibility in a casecontrol study of African American and white populations [40] . However, the latter study did not evaluate the effects of other IL12B polymorphisms.
Morahan et al. [26] found reduced IL12B gene transcription and decreased secretion of IL-12p70 in asthmatic children with IL12B promoter heterozygosity. We found a weaker trend for levels of IL-12p70 expression in IL12B promoter heterozygotes than in homozygotes among the control subjects in our population, but there was substantial overlap of levels between the 2 groups, as well as great variation in the levels of IL-12 among individuals. Taken together, the current functional assays of levels of IL-12 expression are confounded by the large natural variation in cytokine production among different individuals. A better standardized biologic assay system is needed to dissect genotype-phenotype correlation.
In summary, the present study supports the association between IL12B intron 2 polymorphism and TB and between specific haplotypes and TB. Novel risk and protective haplotypes of IL12B have been identified, of which haplotype K was found to be strongly linked to TB susceptibility and haplotype B was found to confer a protective effect. Further genetic and biologic studies of these haplotypes should render valuable insight into TB susceptibility.
APPENDIX
IL12B genotype frequencies in culture-or smear-positive patients with tuberculosis (TB) and in control subjects. a Genotype frequencies at each polymorphic locus were compared between the patients with TB and the control subjects, and ORs were calculated by assigning the reference value (1.0) to the homozygous genotype that was more frequent in the control subjects than in the patients with TB. The OR and P values were calculated by multiple logistic regression analysis, adjusted for the age and sex of the patients with TB and the control subjects. was P ! .05 considered to be significant.
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